Crohn's Disease and Colitis Trial, Recruiting NCT06001450 Sponsor: Icahn School of Medicine at Mount Sinai Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT06001450
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be able to sign and date a consent form agreeing to take part in the study
  • You are currently pregnant, or planning to become pregnant soon and willing to enroll the baby you are pregnant with
  • You are 18 years old or older
  • You are able to speak and understand English (the study questionnaires are only available in English)
  • You are of any ethnicity
  • You are the spouse, a household family member (such as a sibling or parent), or a child of a pregnant person who is already enrolled in the study

Who may not be able to join:

  • People who are not able to give their consent to take part in the study
  • People who have been diagnosed with a pregnancy complication, such as a pregnancy loss, a condition causing dangerously high blood pressure during pregnancy, severe pregnancy-related nausea and vomiting, or an active infection related to the pregnancy (confirm with trial site if you are unsure whether your condition applies)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Manasi Agrawal, MD, MS, Icahn School of Medicine at Mount Sinai

Phone: 212-659-6710

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 August 2023
Est. completion
31 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Microplastics quantification

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov